WHO decision challenges West to recognise Chinese Covid-19 vaccines

Published July 1, 2021
The WHO has already given the green light to the two Chinese jabs, made by Sinovac and Sinopharm. — AFP/File
The WHO has already given the green light to the two Chinese jabs, made by Sinovac and Sinopharm. — AFP/File

The World Health Organisation (WHO) said on Thursday that any Covid-19 vaccines it has authorised for emergency use should be recognised by countries as they open up their borders to inoculated travellers.

The move could challenge Western countries to broaden their acceptance of two apparently less effective Chinese vaccines, which the UN health agency has licensed but most European and North American countries have not.

In addition to vaccines by Pfizer-BioNTech, Moderna Inc, AstraZeneca and Johnson & Johnson, the WHO has also given the green light to the two Chinese jabs, made by Sinovac and Sinopharm.

In its aim to restore travel across Europe, the European Union (EU) said in May that it would only recognise people as vaccinated if they had received shots licensed by the European Medicines Agency — although it’s up to individual countries if they wish to let in travellers who have received other vaccines, including Russia’s Sputnik V. The EU drug regulator is currently considering licensing China’s Sinovac vaccine, but there is no timeline on a decision.

“Any measure that only allows people protected by a subset of WHO-approved vaccines to benefit from the reopening of travel ... would effectively create a two-tier system, further widening the global vaccine divide and exacerbating the inequities we have already seen in the distribution of Covid-19 vaccines,” a WHO statement said on Thursday. “It would negatively impact the growth of economies that are already suffering the most.”

The WHO said such moves are “undermining confidence in life-saving vaccines that have already been shown to be safe and effective”. In its reviews of the two Chinese vaccines, the UN health agency said both were found to significantly reduce the risk of hospitalisations and deaths.

The two Chinese shots are “inactivated” vaccines, made with killed coronavirus, whereas the Western-made shots are made with newer technologies that instead target the “spike” protein that coats the surface of the coronavirus.

Although Western countries have largely relied on vaccines made in the US and Europe, such as Pfizer-BioNTech and AstraZeneca, many developing countries including Pakistan have used the Chinese-made shots.

Earlier this year, the head of China’s Centre for Disease Control and Prevention acknowledged that the effectiveness of its home-grown shots was low. Numerous countries that have used millions of doses of the two Chinese shots, including the Seychelles and Bahrain, have seen Covid-19 surges even with relatively high levels of immunisation.

Opinion

The price of chocolate

The price of chocolate

Little attention is paid to any long-term strategy which might prevent vulnerable children from working in homes where they are in danger.

Editorial

Cholistan project
Updated 18 Feb, 2025

Cholistan project

GPI goals align with Pakistan's broader economic aims but the manner in which the initiative was launched raises questions.
Right to know
18 Feb, 2025

Right to know

IT is an unfortunate paradox that while on paper Pakistan has some of the most impressive right to information laws,...
Dam dispute
18 Feb, 2025

Dam dispute

THE situation in Chilas needs attention and a fair-minded approach so that it can be resolved amicably. Diamer ...
Climate funding gap
Updated 17 Feb, 2025

Climate funding gap

Pakistan must boost its institutional capacity to develop bankable climate projects.
UN monitoring report
Updated 17 Feb, 2025

UN monitoring report

Pakistan must press Kabul diplomatically over its tolerance of TTP terrorism.
Tax policy reform
17 Feb, 2025

Tax policy reform

THE cabinet’s decision to create a Tax Policy Office at the finance ministry has raised hopes that tax policy is...